0001799869-20-000002.txt : 20200203 0001799869-20-000002.hdr.sgml : 20200203 20200203171021 ACCESSION NUMBER: 0001799869-20-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200131 FILED AS OF DATE: 20200203 DATE AS OF CHANGE: 20200203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Strauss David Eric CENTRAL INDEX KEY: 0001799869 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36783 FILM NUMBER: 20569560 MAIL ADDRESS: STREET 1: 2130 W. HOLCOMBE BLVD., STE. 800 CITY: HOUSTON STATE: TX ZIP: 77030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001358403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201450200 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 BUSINESS PHONE: (832) 384-1100 MAIL ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 FORMER COMPANY: FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060405 4 1 wf-form4_158076780411407.xml FORM 4 X0306 4 2020-01-31 0 0001358403 BELLICUM PHARMACEUTICALS, INC BLCM 0001799869 Strauss David Eric C/O BELLICUM PHARMACEUTICALS, INC. 611 GATEWAY BLVD., SUITE 820 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Director, Corporate Controller Stock Option (right to buy) 1.22 2020-01-31 4 A 0 156000 0 A 2030-01-30 Common Stock 156000.0 156000 D 25% of the shares subject to the stock option vest and become exercisable on January 31, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter. /s/ David E. Strauss 2020-01-31